Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 263,119 shares of BLFS, which is worth approximately $6.95 Million. The most recent transaction as insider was on Jun 21, 2023, when has been sold 10,000 shares (Common Stock) at a price of $22.97 per share, resulting in proceeds of $229,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K

17.18% 3M change

4.93% 12M change

Total Value Held $6.95 Million

Aby J. Mathew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 21 2023	SELL Open market or private sale	$229,700 $22.97 p/Share	10,000 Reduced 3.54%	272,614 Common Stock
Jun 21 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.42%	282,614 Common Stock
May 31 2023	SELL Open market or private sale	$11,697 $23.21 p/Share	504 Reduced 0.18%	272,614 Common Stock
May 25 2023	SELL Open market or private sale	$223,299 $22.33 p/Share	10,000 Reduced 3.53%	273,118 Common Stock
May 25 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.41%	283,118 Common Stock
May 24 2023	SELL Open market or private sale	$221,400 $22.14 p/Share	10,000 Reduced 3.53%	273,118 Common Stock
May 24 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.41%	283,118 Common Stock
May 15 2023	SELL Open market or private sale	$2,338 $18.71 p/Share	125 Reduced 0.05%	273,118 Common Stock
Apr 20 2023	SELL Open market or private sale	$192,500 $19.25 p/Share	10,000 Reduced 3.59%	268,352 Common Stock
Apr 20 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.47%	278,352 Common Stock
Apr 19 2023	SELL Open market or private sale	$194,700 $19.47 p/Share	10,000 Reduced 3.59%	268,352 Common Stock
Apr 19 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.47%	278,352 Common Stock
Apr 06 2023	SELL Open market or private sale	$41,922 $20.03 p/Share	2,093 Reduced 0.77%	268,352 Common Stock
Mar 29 2023	SELL Open market or private sale	$15,279 $20.62 p/Share	741 Reduced 0.27%	270,445 Common Stock
Mar 23 2023	SELL Open market or private sale	$217,900 $21.79 p/Share	10,000 Reduced 3.56%	271,186 Common Stock
Mar 23 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.43%	281,186 Common Stock
Mar 22 2023	SELL Open market or private sale	$214,400 $21.44 p/Share	10,000 Reduced 3.56%	271,186 Common Stock
Mar 22 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.43%	281,186 Common Stock
Mar 07 2023	SELL Open market or private sale	$9,524 $22.95 p/Share	415 Reduced 0.15%	271,186 Common Stock
Mar 01 2023	SELL Open market or private sale	$47,456 $22.75 p/Share	2,086 Reduced 0.76%	271,601 Common Stock
Feb 09 2023	SELL Open market or private sale	$1,918 $24.6 p/Share	78 Reduced 0.03%	273,687 Common Stock
Feb 02 2023	SELL Open market or private sale	$244,300 $24.43 p/Share	10,000 Reduced 3.52%	273,765 Common Stock
Feb 02 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.42%	282,765 Common Stock
Feb 01 2023	SELL Open market or private sale	$228,700 $22.87 p/Share	10,000 Reduced 3.52%	273,765 Common Stock
Feb 01 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.4%	283,765 Common Stock

AJM

Aby J. Mathew

EVP & Chief Scientific Officer

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account